中国兽药杂志
中國獸藥雜誌
중국수약잡지
CHINESE JOURNAL OF VETERINARY DRUG
2015年
4期
12-16
,共5页
李爽%张杏%崔栩%刘海燕%苏敬良%金忠辉
李爽%張杏%崔栩%劉海燕%囌敬良%金忠輝
리상%장행%최허%류해연%소경량%금충휘
猪α干扰素%表达%基因型%抗病毒活性
豬α榦擾素%錶達%基因型%抗病毒活性
저α간우소%표체%기인형%항병독활성
porcine interferon-α%expression%genotype%antiviral activity
利用RT-PCR方法从猪肝细胞总RNA中扩增出编码猪α干扰素基因,根据大肠杆菌偏嗜性及活性位点改造基因并克隆至原核表达载体pET21a,转化大肠杆菌BL21( DE3)进行蛋白诱导表达和鉴定。重组蛋白以包涵体形式表达,经变-复性及纯化处理后,获得多种不同基因型的高纯度猪α干扰素。用细胞病变抑制法在MDBK/VSV系统上进行抗病毒活性测定,结果表明经过基因改造的猪α干扰素(PoIFN-M6)具有更高抗病毒活性,约为2.97×108 U/mg。本研究为猪α干扰素基因工程产品的研发及其在临床兽医的应用奠定基础。
利用RT-PCR方法從豬肝細胞總RNA中擴增齣編碼豬α榦擾素基因,根據大腸桿菌偏嗜性及活性位點改造基因併剋隆至原覈錶達載體pET21a,轉化大腸桿菌BL21( DE3)進行蛋白誘導錶達和鑒定。重組蛋白以包涵體形式錶達,經變-複性及純化處理後,穫得多種不同基因型的高純度豬α榦擾素。用細胞病變抑製法在MDBK/VSV繫統上進行抗病毒活性測定,結果錶明經過基因改造的豬α榦擾素(PoIFN-M6)具有更高抗病毒活性,約為2.97×108 U/mg。本研究為豬α榦擾素基因工程產品的研髮及其在臨床獸醫的應用奠定基礎。
이용RT-PCR방법종저간세포총RNA중확증출편마저α간우소기인,근거대장간균편기성급활성위점개조기인병극륭지원핵표체재체pET21a,전화대장간균BL21( DE3)진행단백유도표체화감정。중조단백이포함체형식표체,경변-복성급순화처리후,획득다충불동기인형적고순도저α간우소。용세포병변억제법재MDBK/VSV계통상진행항병독활성측정,결과표명경과기인개조적저α간우소(PoIFN-M6)구유경고항병독활성,약위2.97×108 U/mg。본연구위저α간우소기인공정산품적연발급기재림상수의적응용전정기출。
The aim of this study is to obtain porcine interferon-αwith high antiviral activity. Total RNA extracted from swine liver was used for the generation of the porcine interferon-αcDNA. Here we optimized the codon usage of the gene for E. coli. Then the reconstructed fragments were cloned into vector pET21a to obtain the different genotypes of interferon-α, and expressed in E. coli BL21 ( DE3 ) . The results showed that the protein was expressed as inclusion body. After dissolution, re-naturation and purification, we gained the pure protein. The effect of the reconstructed porcine interferon-α on reduction of viral cytopathic effect ( CPE) was detected in MDBK cells infected with vesicular stomatitis virus ( VSV) . As a result, the protein PoIFN-M6 was verified to have a high antivital activity by CPE inhibition test, which was about 2. 97 × 108 U/mg. The research laid the foundation for the genetic expression of porcine interferon-α and the clinical use of it.